Durable vision improvement after a single intravitreal treatment with antisense oligonucleotide in CEP2 90-LCA: Replication in two eyes.
American journal of ophthalmology case reports（2023）
摘要
These results suggest that sepofarsen reinjection intervals may need to be longer than 2 years.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要